We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$72.5M
AUM Growth
+$956K
Cap. Flow
+$1.31M
Cap. Flow %
1.81%
Top 10 Hldgs %
68.94%
Holding
88
New
10
Increased
5
Reduced
17
Closed
17

Sector Composition

Rank Sector Weight
1 Healthcare 60.54%
2 Energy 29.19%
3 Technology 7.65%
4 Communication Services 1.77%
5 Industrials 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDYA icon
76
IDEAYA Biosciences
IDYA
$3.47B
-173,500
Closed -$2.39M
IMTX icon
77
Immatics
IMTX
$1.34B
-10,300
Closed -$90K
LNTH icon
78
Lantheus
LNTH
$6.61B
-12,900
Closed -$852K
SEGG
79
Sports Entertainment Gaming Global Corp
SEGG
$8.64M
-40
Closed -$63K
LTRYW icon
80
Sports Entertainment Gaming Global Corp Warrants
LTRYW
$785
-125,000
Closed -$25K
ORIO
81
Orion Digital Corp
ORIO
$15.6M
-6,497
Closed -$17K
MRVI icon
82
Maravai LifeSciences
MRVI
$946M
-24,500
Closed -$696K
NTRA icon
83
Natera
NTRA
$39.3B
-7,000
Closed -$248K
RYTM icon
84
Rhythm Pharmaceuticals
RYTM
$7.59B
-27,500
Closed -$114K
ABTC
85
American Bitcoin Corp
ABTC
$477M
-4
Closed -$18K
LTHM
86
DELISTED
Livent Corporation
LTHM
-6,000
Closed -$136K
AUD
87
DELISTED
Audacy, Inc.
AUD
-97,500
Closed -$92K
AMPE
88
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-972
Closed -$49K

Similar funds

ACT Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, ACT Capital Management held 88 positions worth $72.5M, up 1.3% from $71.5M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

ACT Capital Management's Q3 2022 filing shows 10 new, 5 increased, 17 reduced and 17 closed positions. Its largest new stake was Axsome Therapeutics: 73,000 shares worth $3.26M. The largest sale was IDEAYA Biosciences, an estimated $2.39M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 67% a quarter earlier, followed by Energy and Technology.

  • ACT Capital Management's largest Q3 2022 buy was Axsome Therapeutics: 73,000 shares worth $3.26M.
  • ACT Capital Management added most to ExxonMobil in Q3 2022, an estimated $2.26M increase.
  • ACT Capital Management's biggest Q3 2022 reduction was Arcturus Therapeutics, cutting an estimated $1.78M.
  • ACT Capital Management fully exited IDEAYA Biosciences in Q3 2022, selling an estimated $2.39M.
  • ACT Capital Management's ten largest holdings make up 69% of its $72.5M portfolio in Q3 2022.
  • ACT Capital Management opened 10 new positions and closed 17 in Q3 2022.
  • ACT Capital Management's portfolio value rose 1.3% quarter-over-quarter to $72.5M.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.